Premium
LONG‐TERM CONTROL OF POLYCYTHEMIA RUBRA VERA WITH RECOMBINANT ALPHA INTERFERON
Author(s) -
CLEMONS M. J.,
WILLIAMS Y. F.,
GOLDMAN J. M.,
BARRETT A. J.
Publication year - 1996
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/(sici)1099-1069(199603)14:1<37::aid-hon564>3.0.co;2-f
Subject(s) - polycythemia vera , polycythemia rubra vera , medicine , term (time) , alpha (finance) , recombinant dna , chemistry , surgery , physics , biochemistry , gene , construct validity , quantum mechanics , patient satisfaction
The natural history of PRV is characterized by a prolonged period of myeloproliferation chiefly affecting the red cell series. It can be controlled by venesection and cytotoxic agents. In this case report the patient declined further ‘standard’ chemotherapy to control his disease and the use of relatively low doses of IFN‐a was successful in our patient in controlling myeloproliferation and stabilizing the disease over a prolonged period. These results support the use of IFN‐a, not only as a means of myelosuppression in PRV but also as an agent with the potential to prevent disease progression.